Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Bicara Therapeutics, a clinical-stage biopharmaceutical company focused on bifunctional therapies for solid tumors, awarded inducement stock option grants totaling 191,425 shares to four new employees under its 2026 Inducement Plan. The grants were issued as a material inducement to employment and approved by the compensation committee in accordanc…